Coloplast AS/ DK0060448595 /
| 04/11/2024 16:26:24 | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 130.0000USD | - | 207 Turnover: 26,910 |
-Bid Size: - | -Ask Size: - | 29.72 bill.USD | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 22.21 DKK | 0.32% |
| EPS Diluted: | - DKK | 0.41% |
| Revenues per Share: | 109.05 DKK | 2.54% |
| Book Value per Share: | 77.00 DKK | 97.15% |
| Cash Flow per Share: | 18.81 DKK | -21.68% |
| Dividend per Share: | 21.00 DKK | 5.00% |
| Total | in mill. | |
| Revenues: | 24,500.00 DKK | 8.51% |
| Net Income: | 4,783.00 DKK | 1.64% |
| Operating Cash Flow: | 4,226.00 DKK | - |
| Cash and Cash Equivalents: | 911.00 DKK | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 41.38 | 33.66 |
| P/S Ratio: | 8.43 | 6.86 |
| P/BV ratio: | 11.93 | 9.71 |
| P/CF Ratio: | 48.86 | 39.74 |
| PEG: | 130.87 | 106.46 |
| Earnings Yield: | 2.42% | 2.97% |
| Dividend Yield: | 2.29% | 2.81% |
| Market Capitalization | ||
| Market Capitalization: | 29.72 bill. USD | 24.88 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | 1.87 mill. USD | 1.56 mill. USD |
| Shares Outstanding: | 224.66 mill. | |
Profitability
| Gross Profit Margin: | 66.64% |
| EBIT Margin: | 27.64% |
| Net Profit Margin: | 19.52% |
| Return on Equity: | 27.65% |
| Return on Assets: | 9.93% |
Financial Strength
| Liquidity I / Cash Ratio: | 5.59% |
| Liquidity II / Quick Ratio: | 32.04% |
| Liquidity III / Current Ratio: | 60.92% |
| Debt / Equity Ratio: | 178.39% |
| Dynam. Debt / Equity Ratio: | 730.24% |
Efficiency
| Employees: | 15,913 |
| Personal Expenses / Employee: | - DKK |
| Revenues / Employee: | 1,539,621.69 DKK |
| Net Income / Employee: | 300,571.86 DKK |
| Total Assets / Employee: | 3,026,393.51 DKK |
| * Fiscal Year End: | 30/09/2023 |
| Accounting Standard: | IFRS |
| Currency: | DKK |
